Diabetes drug linked to heart failure risk

Canadian scientists say they have discovered rosiglitazone (Avandia) a type 2 diabetes drug, might be linked with increased risk of heart failure and death. The scientists from the University of Toronto and the Sunnybrook Health Sciences Center in Toronto, said the linkage was found among older patients, compared to a similar drug, pioglitazone (Actos). The scientists utilised prescription records ...

Still Prescribing Killer Diabetes Drug?

Stop prescribing killer diabetes drug, scientists warn (Guardian Unlimited)
Rosiglitazone, brand name Avandia, has higher rates of heart failure and death than similar alternative Scientists say doctors should stop prescribing a commonly used diabetes drug, after studies show that it is linked to higher rates of heart failure and death than a similar alternative. David Juurlink, a Toronto-based pharmacologist and lead author of a paper published online today by the ...

Avandia Heart Failure Risk More Than Actos

Avandia Raises Heart Failure Risk More Than Actos (MedicineNet.com)
Title: Avandia Raises Heart Failure Risk More Than Actos Category: Health News Created: 8/19/2009 8:10:00 AM Last Editorial Review: 8/19/2009

FDA approves diabetes drug from two manufacturers

FDA approves diabetes drug from two area manufacturers (Worcester Telegram & Gazette)
Bristol-Myers Squibb Co. and AstraZeneca Plc won U.S. approval for a new diabetes treatment to compete with Merck & Co.'s Januvia.